Cancer screening: overview and prospects.
In Table 4, current "state-of-the-art" screening for various cancers is summarized. It is fair to say that, unfortunately, only a minority of the tumors do have proven screening methods that lead to a lower disease-specific mortality. Given the relative lack of improvement in survival rates over the last few decades, this area should be a priority for research endeavors.
Berkel
H J
HJ
Center for Excellence in Cancer Research, Treatment, and Education, LSU Medical School, Shreveport, USA.
D001943:Breast Neoplasms / Q000517:prevention & control; D018450:Disease Progression; D005260:Female; D006801:Humans; D008297:Male; D008327:Mammography; D008403:Mass Screening; D009369:Neoplasms / Q000517:prevention & control*; D011471:Prostatic Neoplasms / Q000517:prevention & control; D012680:Sensitivity and Specificity; D002583:Uterine Cervical Neoplasms / Q000517:prevention & control